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The Rac proteins, RacI and Rac2, are essential components of
the NADPH oxidase system ofphagocytes and regulate the actin
assembly associated with membrane ruffling. These functions are
controlled by the GTP-bound form of Rac. The biochemical
interaction between Rac and its only known GDP-dissociation
stimulator (termed smgGDS) was characterized. SmgGDS was
able to stimulate the incorporation of guanosine 5'-[y-thio]-
triphosphate GTP[yS] into the RhoA, Rac2, Racl, RaplA and
CDC42Hs GTP-binding proteins, but the activity was greatest
toward RhoA and Rac2. Isoprenoid modification of these
proteins was not absolutely required for the interaction with
smgGDS. Interestingly, the activity of smgGDS toward Racl
could not be observed in a [3H]GDP/GTP exchange assay under
INTRODUCTION
The Rac proteins, RacI and Rac2, are members of the Rho
family oflow molecular weight GTP-binding proteins (LMWGs).
RacI has been shown to be involved in growth factor-stimulated
actin filament assembly associated with the cellular processes of
pinocytosis and membrane ruffling [1]. Rac2 and RacI have also
been demonstrated to be crucial components of the phagocyte
NADPH oxidase system, which is responsible for generating
superoxide anion used in defending the human body from
bacterial invasion [2-5].
As with all other GTP-binding proteins, the Rac proteins
consist oftwo interconvertible guanine nucleotide binding forms,
the active GTP-bound form and the inactive GDP-bound form.
Switching between these two forms is regulated by three different
types of regulatory proteins: GTPase-activating proteins which
stimulate GTP hydrolysis, GDP dissociation inhibitors (GDIs)
which inhibit GDP dissociation and may also inhibit GTP
hydrolysis, and GDP dissociation stimulators (GDSs) which
stimulate the exchange of GDP for GTP [6,7]. In resting
phagocytes, the Rac proteins are maintained in an inactive
cytosolic form by complexation with Rho-GDI [2,8-10]. Stimu-
lation of cells with agonists (e.g. N-formylmethionyl-leucyl-
phenylalanine, phorbol 12-myristate 13-acetate) which induce
the production of superoxide anion activates the Rac proteins
and induces their translocation, along with two other cytosolic
oxidase components -P47phox and p670pho from cytoplasm to
cell membrane to form the functioning NADPH oxidase [11].
conditions where it stimulated incorporation of GTP[yS] into
Racl. We determined that smgGDS prevented the loss of Racl
activity during the [3H]GDP/GTP exchange assay by dem-
onstrating the ability of sm$GDSjtq inhibit the loss of Racl
GTP[yS]-binding during incu^bations at 30 'C. This stabilizing
effect was exactly counterbalanced by the ability of smgGDS to
stimulate the release of [3H]GDP from Racl, thereby producing
no net observable effect in the exchange assay. SmgGDS was
able to effectively stimulate the release of GDP but not GTP[yS]
from Racl. SmgGDS maintains Racl in a nucleotide-free form
after release of GDP, indicating that the reaction between Racl
and smgGDS involves a substituted enzyme mechanism.
The mechanism(s) of Rac protein activation in cells is not yet
known. However, activation of superoxide formation stimulated
by the Rac proteins in broken cell assays is dependent on the
exchange ofGTP for GDP on Rac catalysed by endogenous [12]
or exogenously added exchange proteins [4]. Rac can also be
induced to 'translocate' to the membrane in vitro by the
addition of guanosine-5'-[y-thio]triphosphate (GTP[yS]) ([13]
G. M. Bokoch, B. P. Bohl and T.-H. Chuang, unpublished
work). Currently, the only protein reported to be able to catalyse
nucleotide exchange on Rac is the smgGDS originally described
by Takai and co-workers [6,14,15].
SmgGDS is a 61 kD protein with 558 amino acid residues,
originally isolated from bovine brain cytosol [14] and cloned by
Kaibuchi et al. [15]. This protein and Dbl, a human oncogene
product, are the only two proteins reported so far to have
GDP/GTP exchange activity toward Rho family proteins [16,17].
Dbl, however, has substantially more activity toward CDC42Hs
and RhoA than toward Rac proteins [17,18]. SmgGDS appears
to be distinct from Dbl and other known exchange-factors which
act solely on Ras, such as CDC25, SCD25, SOS, Ras-GRF and
Vav [19], in that it has been shown to have GDP/GTP exchange
activity toward a number of small GTP-binding proteins, in-
cluding Racl, Rac2, RhoA, k-Ras, and RaplB [16]. An
isoprenylated carboxyl terminus of these GTP-binding proteins
has been reported to be required for functional and physical
interactions with smgGDS [20,21].
In this study, we determined the biochemical characteristics of
the interaction between purified recombinant smgGDS and
Abbreviations used: GDS, GDP dissociation stimulator (smgGDS refers to the protein originally described by Takai, et al.); LMWG, low molecular
weight GTP-binding protein; GTP[yS], guanosine 5'-[y-thio]-triphosphate, DMPC, dimyristoylphosphatidylcholine; GDI, GTP-dissociation inhibitor;
DTT, dithiothreitol.
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LMWG. Our data indicate that smgGDS stimulates the in-
corporation of GTP[yS] into a number of Ras-related GTP-
binding proteins, and that this activity is observed with both
post-translationally isoprenylated and non-prenylated forms of
these proteins. We found that exchange activity was more potent
towards RhoA and Rac2 than towards Racl, RaplA and
CDC42Hs. SmgGDS releases GDP from Racl and has the
previously unreported effect of stabilizing both nucleotide-bound
and -free forms of Racl from denaturation in vitro. Our data
indicate that a substituted enzyme kinetics mechanism governs




Recombinant unprocessed Racl, CDC42Hs and RhoA were
purified from overexpressing Escherichia coli [8,12]. Processed
(isoprenylated) Racl and RaplA were isolated from cell mem-
branes after protein expression in a baculovirus/Sf9 insect cell
system [12,22]. GST-Racl fusion protein was purified from
overexpressing E. coli (a gift from Dr. Alan Hall). [35S]GTP[yS]
(1400 Ci/mmol) and [3H]GDP (32 Ci/mmol) were purchased
from Dupont-NEN. All other reagents used were of the best
grade commercially available.
Expression and purfflcation of recombinant smgGDS
The smgGDS cDNA was generated by PCR amplification from
a bovine brain cDNA library. A cDNA fragment encoding
amino acid residues 1-240 of smgGDS was obtained by using a
5'-oligonucleotide primer (GGGGGATCCGGTACCATGGA-
TAATCTCAGTGATACCTTGAAGAAGCTGAAGATAAC-
AGC) which contains a BamHl site and a Ncol site, and a 3'-
oligonucleotide primer (GTTTTGAGCTCAGCGATATCC)
containing an Sstl site. A cDNA fragment encoding amino acid
residues 241-558 was amplified by using a 5'-oligonucleotide
primer (CGCTGAGCTCAAAACCGC) which contains an Sstl
site, and 3'-oligonucleotide primer (GGGGGATCCTCAGCTT-
TCCACAGCCAGTCTCTGCTCCTGTGAGAGAGGC) con-
taining a BamHl site. Both PCR amplified products were
subcloned into an M13mpl8 vector. Single-stranded DNA was
sequenced by using sequenase, essentially as described by the
manufacturer (Upstate Biotechnology, Inc). The cDNA sequence
was identical at the amino acid level to the previously published
sequence for bovine smgGDS [15], except for an alanine for
cysteine substitution at codon 335. This substitution was con-
firmed with cDNAs from three independent PCR amplifications.
A similar substitution was reported in the human homologue
[23], and is therefore not likely to perturb smgGDS function. The
full length cDNA was subcloned into a bacterial expression
vector, PET Ild (Novagen), at the Ncol and BamHI sites and
transformed into E. coli strain BL21 (DE3) for protein expression.
The transformed cells were induced with 1 mM isopropyl- l-thio-
/J-D-galactopyranoside to produce the recombinant smgGDS.
For protein purification, the cells were harvested by centri-
fugation, suspended in buffer A [25 mM Tris pH = 8, 1 mM
EDTA, 1 mM dithiothreitol (DTT)] plus 1 mM phenylmethane-
sulphonyl fluoride, 0.1 0% Triton X-100, 0.2 mg/ml lysozyme,
incubated at 30 °C for 20 min, and then broken by sonication.
After centrifugation, proteins in the supernatant were separated
by a DEAE-Sephacel column equilibrated with buffer A.
SmgGDS was resolved with a 0-1 M linear gradient of NaCl in
monitored by u.v. spectrophotometer and SDS/PAGE visuali-
zation. After dialysis against buffer A, further purification was
performed with a Pharmacia f.p.l.c. 5/5 MonoQ column equili-
brated with buffer A and eluted with a 0-0.6 M NaCl gradient in
the same buffer. The isolated smgGDS was estimated by SDS/
PAGE to be more than 95% pure.
[35S]GTPyS incorporation assay
The ability of smgGDS to stimulate the incorporation of
GTP[yS] into various LMWGs was determined by incubating
60 nM of each LMWG with 240 nM smgGDS in a solution
containing 27.0 mM Tris/HCl (pH 8), 4.5 mM Hepes (pH 8),
1 mM DTT, 5.1 mM EDTA, 10.2 mM MgCl2 (free Mg2+ =
5.1 mM) and 2.0 ,uM [35S]GTP[yS] (- 2.5 x 104 c.p.m./pmole) at
30 'C. At the indicated times, aliquots were removed and added
to 2 ml of ice-cold stop solution (25 mM Tris/HCl (pH 8),
100 mM NaCl, 30 mM MgCl2, 2 mM DTT, 0.1 mg/ml BSA)
and incorporation of [35S]GTP[yS] into the protein was de-
termined by vacuum filtration on BA-85 nitrocellulose filters and
liquid scintillation counting [8].
[H3]GDP/GTP exchange assay
To determine the activity of smgGDS in the exchange of
prebound [H3]GDP from LMWGs in the presence of exogenous
GTP, the LMWG (60 nM) was first loaded with [3H]GDP in a
solution containing 25 mM Tris/HCl (pH = 8), 1 mM DTT,
40 ,ug/ml BSA, 4.7 mM EDTA, 0.16 mM MgCl2 (36 nM free
Mg2+) and 4.5,uM [3H]GDP (104 c.p.m./pmole) at 30 'C for
7 min. In some experiments, dimyristoylphosphatidylcholine
(DMPC) was added at a concentration of 1 mM. This reaction
was stopped by adding MgCl2 to a final concentration of9.15 mM
(final free Mg2+ = 5.5 mM). SmgGDS and unlabelled GTP were
then added to a final concentration of 240 nM and 164 ,tM
respectively to start the reaction. The amount of [3H]GDP
remaining on the LMWG was quantified as indicated in the
[35S]GTP[yS] incorporation assay.
[3H]GDP dissociation assay
This assay was performed essentially the same way as the
[3H]GDP/GTP exchange assay described above except that the
[3H]GDP bound to the LMWG was released by smgGDS in the
absence of any additional exogenous GTP at a free Mg2+
concentration of 7.0 mM.
[3S]GTP[yS] dissociation assay
This assay was performed essentially the same way as the
[H3]GDP-dissociation assay except that the LMWGs were initi-
ally loaded with 2.58 ,uM [35S]GTP[yS].
Stabilization effect of smgGDS toward Racl
Racl protein (60 nM) was loaded with cold GDP and the
concentration of free Mg2+ raised to 7.0 mM to stop the reaction,
as in the [3H]GDP-dissociation assay. After incubation of this
reaction mixture in the presence or absence of 240 nM of
smgGDS at 30 'C for the indicated times, aliquots were removed
and added to an equal volume of 30 ,uM [35S]GTP[yS]
(_ 1 x 104 c.p.m./pmole) and 160 mM EDTA to adjust the final
concentration of free Mg2+ to 165 nM. The reaction was in-
cubated at 30 'C for 7 min, and [35S]GTP[yS] bound to RacI was
buffer A and eluted at a concentration of around 0.4 M, as determined as in the [35S]GTP[yS] incorporation assay.
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Complex formation between Racl and smgGDS
Aliquots of 80 nM GST-Racl fusion protein were preloaded
with or without guanine nucleotides in solution A [25 mM
Tris/HCl (pH 8), 1 mM DTT, 40 ,ug/ml BSA, 4.7 mM EDTA,
0.16 nM MgCl, (36 nM free Mg2`)] containing either 40,uM
GDP or GTP[yS] at 20 °C for 10 min. The reactions were
stopped by the addition of MgCl2 to a final concentration of
9.15 mM (free Mg2+ = 5.5 mM). SmgGDS was then added to a
final concentration of 360 nM and incubated at 20 °C for 10 min.
A 20 #1 slurry of glutathione-sepharose beads was then added to
absorb the protein complexes. After 10 min, the beads were
washed five times with solution A containing either 40 ,uM GDP
or GTP[yS], suspended in Laemmli sample buffer and the proteins
were resolved with SDS/PAGE on 150% gels. Quantities of
complexed smgGDS were determined by Western blotting using
specific antibody raised against the purified recombinant
smgGDS and quantitated by densitometry.
RESULTS
In order to evaluate the activity of smgGDS toward Rac and
other LMWGs, bovine smgGDS was expressed in E. coli and
purified to near homogeneity as described in the Experimental
section. The ability ofsmgGDS to stimulate the incorporation of
[35S]GTP[yS] into various LMWGs was tested under conditions
(i.e. at a high free Mg2" concentration) in which the LMWGs
have very low nucleotide-exchange rates in the absence of
exchange factors [8]. Our initial experiments indicated that
smgGDS was able to stimulate the exchange of [35S]GTP[yS] for
endogenous GDP, both on unprocessed and post-translationally
processed LMWG, as illustrated by the data shown for Racl in
Figure 1. In the presence of smgGDS, we could stimulate the
binding of GTP[yS] to unprocessed RhoA up to a level equal to
the amount of active RhoA protein added to the assay (i.e. 100-%
incorporation of [35S]GTP[yS] after incubation for 50 min at
30 °C; Figure 1). SmgGDS was similarly effective on processed
Rac2. In comparison, smgGDS only stimulated binding of
GTP[yS] to levels of 53 %, 42 %, 32% and 17% ofmaximum for
processed Racl, unprocessed Racl, unprocessed CDC42Hs, and
processed RaplA respectively by 50 min (Figure 1). Essentially
no differences in the kinetics of guanine nucleotide exchange
were observed for any of these proteins, in contrast to the report
by Sasaki et al. [24] that the velocity of the exchange reaction for
Rho was greater than for Rac 1. Thus, smgGDS was more active
toward RhoA and Rac2 than toward the other LMWGs, and
isoprenyl modification ofLMWGs is clearly not required for the
interaction with smgGDS, although a direct comparison between
processed and unprocessed Racl suggests that isoprenylation
may facilitate the interaction.
The ability of smgGDS to stimulate the exchange of prebound
[3H]GDP with exogenous GTP at high free-Mg2" concentration
was also tested. As expected, smgGDS stimulated the release of
[3H]GDP from both RhoA and RaplA (Figure 2). This effect of
smgGDS on GDP dissociation was not observed with Racl
however; a result which appeared to be inconsistent with the
[35S]GTP[yS] incorporation data of Figure 1. When we examined
the effect of smgGDS on the release of prebound [3H]GDP from
Racl under low free-Mg2" concentrations, at which Rac protein
has a relatively high intrinsic GDP dissociation rate [8,25], we
observed that [3H]GDP/GTP exchange was stimulated by
smgGDS (Figure 3). This observation suggested that smgGDS
did indeed have the ability to stimulate the exchange ofGTP for
GDP on Racl under the appropriate assay conditions. Indeed,
we subsequently determined that inclusion of 1 mM DMPC in
Figure 1 SmgGDS-stlmulated incorporation of [N'S]GTP[yS] Into various
LMWGs
Incorporation rate of [35S]GTP[yS] into 60 nM of various LMWGs, as indicated, was determined
as described in the presence (0) or absence ([1) of 240 nM of smgGDS at 30 °C for 50 min.
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Figure 2 SmgGDS-stimulated (3H]GDP/GTP exchange of RhoA (unpro-
cessed), RaplA,,(processed) and Racl (processed) under high free-Mg2+
concentration conditlons
The exchange rate of prebound [3H]GDP from 60 nM of RhoA (a), RaplA (b) and Racl (c) with
exogenous GTP in the presence (+) or absence (-) of 240 nM smgGDS was determined as
described in the Experimental section. The results shown are representative of at least three
independent experiments.
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Figure 3 SmgGDS-stimulated [H]GDP/GTP exchange of processed Racl
under low free-Mg2+ concentration conditions
The exchange-rate of prebound [3H]GDP from 60 nM of processed Racl with exogenous GTP
in the absence (0) or presence of 240 nm of smgGDS (A), or 180 nM of RhoGDI (EO) was
























10 20 30 40 50 0 10 20 30 40 50
Time (min)
Figure 4 NucleoUde-releasing effect of smgGDS toward processed Racl
and RaplA
Racl (60 nM) (a, b) and RaplA (c, d) were preloaded with [3H]GDP (a, b) and [35S]GTP[yS]
(b, d) as described. The nucleotide-bound proteins were then incubated at 30 °C with (+) or
without (-) 240 nM smgGDS in the absence of any exogenous unlabelled nucleotides. Under
these conditions, in the presence of smgGDS only the nucleotide-release rate is detected,
whereas in the absence of smgGDS the apparent nucleotide-release rate is equivalent to the
decay rate of the nucleotide-binding protein.
the high Mg2` assay allowed us to detect readily exchange
activity of smgGDS toward Racl (not shown). This was due to
the ability of this phospholipid to stabilize Racl from denatura-
tion during the course of the assay (see following experiments).
We took advantage of the lability of Racl in the absence of
DMPC to characterize the interaction of smgGDS with an
LMWG.
Working under high Mg2+ conditions in the absence ofDMPC,
we noted (see Figure 2) that the apparent rate of [3H]GDP
dissociation from RacI ( 700% of prebound [3H]GDP lost
during the 50 min assay) was much greater than that from either
RhoA or RaplA (- 300% loss of [3H]GDP over the 50 min
assay). Two possibilities might account for this rapid loss of
GDP from Racl. The first is that Racl has a higher intrinsic
GDP exchange rate than does RhoA or RaplA. The second is
that Racl is not totally stable during the course of the release
assay at 30 °C at high Mg2+, and that part of the rapid loss of
[3H]GDP is actually due to denaturation of the Racl protein. If
the latter possibility were true, then we reasoned that the binding
of smgGDS to Racl might stabilize Racl and prevent degra-
dation, with the stabilization effect exactly counterbalancing the
stimulated exchange of [3H]GDP for GTP induced by smgGDS,
thereby effectively 'masking' our ability to detect the stimulated
release of [3H]GDP in these assays.
We designed experiments to attempt to differentiate between
these two possibilities. The release of [3H]GDP from Racl was
determined as in Figure 2, but in the absence of excess unlabelled
GTP. In the absence of competing nucleotides, any [3H]GDP
released should rebind to the Racl, effectively making this a
measure of the rate of loss of Racl nucleotide-binding activity.
We found that the rate of loss of[3H]GDP under these conditions
was essentially the same as that observed in the presence of excess
unlabelled nucleotide (see Figure 4a and compare Figure 2c).
The loss of bound [3H]GDP in this experiment thus appears to be
due to denaturation; we estimate the decay rate for Rac 1 to have
a half-time of - 30 min at 30 'C. By contrast, RaplA denatured
relatively slowly, with only 20 30% loss of active protein over a
50 min timespan (Figure 4c and d). Since the overall rate of
[3H]GDP dissociation from Racl in Figure 2c had a half-time of
- 20 min at 30 'C, the actual intrinsic rate of GDP dissociation
must be quite low, with most of the loss accounted for by
denaturation of Racl binding-activity during the assay. The
decay rate of [3H]GDP-bound Racl was about the same as the
decay rate for [35S]GTP[yS]-bound Racl (Figure 4b).
Can the binding ofsmgGDS to Racl prevent the denaturation
of the protein that occurs under these assay conditions? Direct
evidence of the stabilizing effect of the smgGDS towards GDP-
bound Racl is shown in Figure 5. We incubated GDP-preloaded
Racl at 30 'C in the presence of high Mg2+, and measured the
amount of active protein remaining at various times in the
presence or absence of smgGDS by rapidly lowering the free
Mg2+ concentration with EDTA and determining the total
amount of [35S]GTP[yS]-binding activity remaining. Figure 5
shows that there was substantial loss of active Racl during the
incubation, and that this decay could be prevented largely by
incubation in the presence of smgGDS. In contrast, addition of
smgGDS (± EDTA) subsequent to the incubation at 30 'C did
not restore binding activity. We therefore conclude that smgGDS
stabilizes the GDP-bound form of Racl in vitro.
It is obvious from Figure 4b that we could detect a stabilizing
effect of smgGDS on the degradation of [35S]GTP[yS]-bound
Racl, while we could not see the stabilizing effect on the
[3H]GDP-bound Racl, even though we knew it occurred based
on the data of Figure 5. SmgGDS appears to stabilize the
GTP[yS]-bound form of Racl but does not stimulate the release
of GTP[yS] from RacI under these assay conditions. Observation
of the stabilizing effect of smgGDS on [3H]GDP-bound Racl
appears to be exactly compensated for by the smgGDS-catalysed
stimulation of the release of [3H]GDP from Racl in the absence
of excess unlabelled GTP. That the ability of smgGDS to
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Figure 5 Stabilization effect of smgGDS towards processed Racl
GOP bound Racl (60 nM) was incubated in the presence (+) or absence (-) of 240 nM
smgGDS at 30 °C. Aliquots were taken at the indicated time-points and the remaining
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Figure 6 The [H]GDP/GTP exchange effect of smgGDS towards processed
Racl
The [3H]GDP/GTP exchange effect of smgGDS toward Racl can be estimated by comparing
the result in Figure 2c with the stabilization effect of smgGDS shown in Figure 5. 0, Data from
Figure 5 which represents the true amount of active Racl in the presence of smgGDS under
the reaction condition. AL Data from Figure 2c which represents the nucleotide exchange rate
of Racl in the presence of smgGDS under the reaction conditions used.
Figure 7 Complex formation between smgGDS and Racl in various
nucleotide-bound states
The amount of smgGDS bound to forms of Racl is shown by Western blotting with a specific
smgGDS polyclonal antibody; the level of Racl in each set of bead precipitates is shown for
comparison as well. The numbers in parentheses at the bottom of each lane represent the
relative amount of smgGDS bound to that particular form of Racl after normalization for the
amount of bound Racl and subtraction of the glutathione bead blank, which was - 10% of
the total smgGDS bound.
(a) (b)
smgGDS smgGDS
Racl * GDP Racl * GDP // GTP
Racl * GDP * smgGDS Racl - GDP * smgGDS smgGDS * GTP
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Racl * smgGDS GTP Racl smgGDS
GTP GDP
Racl * GTP * smgGDS
smgGDS e ,
Racl * GTP
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Figure 8 Possible mechanisms for the interaction between Racl and
smgGDS
(a) Substituted enzyme mechanism; and (b) ternary complex mechanism.
stimulate the release of GDP is independent of the presence of
excess GTP is demonstrated in Figures 2b and 4c, where the
release of prebound [3H]GDP from RaplA stimulated by
smgGDS is the same in the presence or absence of exogenous
GTP. In addition, unlike the Racl protein, release of prebound
[35S]GTP[yS] from RaplA stimulated by smgGDS could be
detected in the absence ofany exogenous nucleotides (Figure 4d).
Using the data of Figure 5 as a measure of the actual amount
of active Racl present during the assay in the presence of
smgGDS, we can 'correct' the data of Figure 2c to compensate
for the actual level of active Racl in the presence of smgGDS;
the [3H]GDP-releasing effect of smgGDS on Racl is thereby
revealed (Figure 6). This data is in good agreement with the
ability of smgGDS to stimulate [3H]GDP release from Racl in
the presence of DMPC (not shown).
We examined the ability of smgGDS to form physical com-
plexes with various guanine-nucleotide-bound forms of Racl
(Figure 7). Effective complex formation between RaclI-GDP and
nucleotide-free RacI and smgGDS was readily detectable, while
complexation with Racl-GTP was substantially less at the same
protein ratios. This weaker affinity for Rac in the GTP-form
would be consistent with the need for the two proteins to
dissociate once GTP/GDP exchange has taken place (see
Figure 8).
DISCUSSION
The stabilizing effect of smgGDS-binding has not been noted
previously. The data of Figures 4, 5, and 7 show that smgGDS
binds to and stabilizes both nucleotide-bound forms of Racl, as
well as a nucleotide-free form of the protein. The formation of a
stable complex ofsmgGDS with nucleotide-free Racl is indicated
by the ability of smgGDS to release prebound [3H]GDP from
Racl in the absence of exogenous GTP (Figure 4a). Under that
circumstance, the nucleotide-depleted Racl protein would be
expected to be unstable unless maintained in an active, nucleotide-
free form by smgGDS. The latter was shown to be true because
the nucleotide-depleted Racl retains its GTP-binding activity
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(Figure 5) only in the presence of smgGDS. Finally, direct
physical complexes of nucleotide-free Rac with smgGDS could
be detected (Figure 7).
Two basic kinetic schemes can be proposed to explain the
mechanism by which nucleotide exchange is stimulated by
exchange factors such as smgGDS: an enzyme-substituted (ping-
pong) mechanism and a ternary complex mechanism, as illu-
strated in Figure 8. A stable transition complex between smgGDS
and the nucleotide-free form of Racl supports the concept that
the reaction between smgGDS and Racl follows a substituted
enzyme mechanism. This mechanism is similar to that proposed
for SDC25, a Saccharomyces cerevesiae gene product which
stimulates nucleotide exchange on Ras [26,27], as well as for the
guanine nucleotide exchange reaction catalysed by eukaryotic
initiation factor 2 [28], and the E. coli elongation factor Ts [29].
These results predict a lower affinity ofsmgGDS for GTP-bound
LMWG proteins, and this was observed when complex formation
was assessed directly (Figure 7).
Contrary to previous reports of Takai et al. [6], we observed
that smgGDS was active towards both post-translationally
processed (isoprenylated) and unprocessed Racl. The isoprenyl
modification ofLMWGs appeared not to be absolutely required
for interaction with smgGDS, and this was further confirmed by
the high activity of smgGDS towards unprocessed RhoA.
SmgGDS has been reported to have activity only toward
processed Rapl, c-K-Ras, Rho and Rac [16,20,21], and has been
shown to induce the release of Rapl and c-K-Ras from cell
membranes to cytoplasm [30,31], probably by binding to the
isoprenylated C-terminus and preventing membrane association.
The isoprenylated C-terminus region of Rapl was shown to bind
to smgGDS by a cross-linking method [32]. In light of our
current data, it is likely that smgGDS interacts with more than
one site on the LMWGs and that the isoprenyl portion is not
absolutely required for catalysed nucleotide exchange to occur.
Isoprenylation might enhance the smgGDS binding, as we
observed that smgGDS has slightly higher activity toward
processed Racl than to unprocessed Racl (Figure 1).
Our results also indicate that smgGDS has greater capability
to stimulate nucleotide exchange on RhoA and Rac2 than on
Racl, CDC42Hs or RaplA (both processed and unprocessed),
implying that ifsmgGDS is indeed the sole stimulatory exchange-
regulator for both Racl and Rac2, then Rac2 might be activated
by smgGDS more readily than Racl. Sasaki et al. [24] have
suggested that, based upon the differing kinetics of Rho and
Racl activation by smgGDS they observed, Rho would be a
primary target of smgGDS. However, we see very effective
stimulation of GTP/GDP exchange on Rac2, comparable to the
activity of smgGDS toward Rho, and we could not detect more
rapid exchange-kinetics when Rho was compared with Racl or
Rac2. Since in the signal transduction pathways linking growth
factors to assembly of the actin cytoskeleton it appears that Rac
is an upstream regulator of Rho [1], it is likely that there exist
other, unidentified stimulatory GTP/GDP exchange regulators
which may be selectively active toward the Rac proteins.
We demonstrated that smgGDS could stimulate both the
incorporation of GTP[yS] and the release of GDP from Racl
and Rac2, although the latter activity was obscured under high
Mg2+ assay conditions in the absence of DMPC by the ability of
smgGDS to stabilize Rac from denaturation which occurred
during the assay. Thus, smgGDS can serve as a positive regulator
for Rac proteins as originally reported by Hiraoka et al. [16], and
Rac2 is an effective substrate. Our observations are of note for
determination of the GTP/GDP exchange capability of other
proteins reported to be potential stimulatory exchange factors
based upon their sequence homology with the nucleotide ex-
change domain of the Dbl proto-oncogene [19]. [3H]GDP dis-
sociation is the most commonly used assay to detect such
activity, and our results indicate that under certain assay
conditions and with certain LMWG, the ability to detect
exchange may be compromised.
In summary, we have described the ability of smgGDS to
stimulate GTP/GDP exchange on various LMWG, showing it to
be most effective toward RhoA and Rac2, and have demonstrated
that smgGDS binding stabilizes the nucleotide-free form of
Racl. The latter supports a substituted enzyme mechanism for
stimulated guanine nucleotide exchange by this regulatory factor.
SmgGDS appears to be capable of acting on both unprocessed
and post-translationally processed forms of LMWG, suggesting
sites of binding that do not absolutely require an isoprenylated
C-terminus.
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